Surgery Partners Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2016	2015	2014	2013	2012
Net Income	-11.9	-54.6	-81.2	-155.6	-110.5	-238.1	9.45	1.43	-65.9	-9.06	Upgrade
Depreciation & Amortization	153.3	149.6	137.9	134.2	116.5	67.4	39.55	34.55	15.06	11.66	Upgrade
Share-Based Compensation	17.7	18.4	17.4	13.2	10.2	9.3	2.02	7.5	0.94	0.46	Upgrade
Other Operating Activities	134.7	45.4	2.7	215.6	77.6	273.6	74.21	41.01	71.84	46.02	Upgrade
Operating Cash Flow	293.8	158.8	87.1	246.9	129.5	144.6	125.24	84.48	21.95	49.08	Upgrade
Operating Cash Flow Growth	85.01%	82.32%	-64.72%	90.66%	-10.44%	15.46%	48.25%	284.90%	-55.28%	5.82%	Upgrade
Capital Expenditures	-63	-67.7	-51.6	15.6	-56	-20.6	-39.11	-33.44	-7.74	-4.15	Upgrade
Acquisitions	-80	-146.4	-285.8	-104.6	-13.8	-106.8	-145.64	-101.4	-263.28	0.53	Upgrade
Change in Investments	-48.9	-82.3	5.4	0	-15.2	0	0	0	0	0	Upgrade
Other Investing Activities	-33.7	-11.5	0.3	0.6	-0.2	-1.5	-	-	-	-	Upgrade
Investing Cash Flow	-225.6	-307.9	-331.7	-88.4	-85.2	-128.9	-184.75	-134.84	-271.02	-3.62	Upgrade
Share Issuance / Repurchase	0	857.7	554.2	0	0	-2	0	250.98	0	0	Upgrade
Debt Issued / Paid	-4.8	-655.5	-55.5	204.6	-10.6	122.1	157.15	-135.71	442.01	118.1	Upgrade
Other Financing Activities	-150.4	-160.1	-182.4	-137.9	-125.3	-126.4	-85.87	-81.9	-131.05	-155.76	Upgrade
Financing Cash Flow	-155.2	42.1	316.3	66.7	-135.9	-6.3	71.28	33.37	310.96	-37.66	Upgrade
Net Cash Flow	-87	-107	71.7	225.2	-91.6	9.4	11.77	-16.99	61.89	7.79	Upgrade
Free Cash Flow	230.8	91.1	35.5	262.5	73.5	124	86.13	51.04	14.21	44.93	Upgrade
Free Cash Flow Growth	153.35%	156.62%	-86.48%	257.14%	-40.73%	43.97%	68.74%	259.12%	-68.36%	7.78%	Upgrade
Free Cash Flow Margin	8.41%	3.59%	1.60%	14.11%	4.01%	7.00%	7.52%	5.32%	3.52%	15.79%	Upgrade
Free Cash Flow Per Share	1.84	0.99	0.49	5.38	1.52	2.58	1.79	1.42	0.44	1.41	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).